In the Laboratory of Medicinal Chemistry, problems at the chemistry-life sciences interface are addressed. A large part of their work concentrates on the development of small molecule modulators of new (i.e., yet unexplored) targets. These modulators can be both enabling chemical tools to interrogate biology or therapeutically useful compounds. From a chemical perspective, much of their work is centered on the chemical synthesis of novel nucleoside, carbohydrate, phosphonate, sphingolipid and bioconjugate chemistry. Several of the running projects deal with the design of new lead structures and PROTACs for the treatment of diseases with unmet medical needs.

The University of Lille, a multidisciplinary institute of excellence at the heart of northwestern Europe, boasts an exceptional cultural and scientific heritage that is an integral part of the history of the Hauts-de-France region. With 72,000 students (9,502 of whom are from overseas), a staff of 6,700, 66 research units and a range of courses that cover all academic disciplines, it is a key stakeholder in the region for education, research and innovation and through its contributions to societal issues. The University also offers 16 courses fully taught in English and 30 run on a bilingual basis.